Log In
BCIQ
Print this Print this
 

SRX246

  Manage Alerts
Collapse Summary General Information
Company Azevan Pharmaceuticals Inc.
DescriptionArginine vasopressin 1a (V1a) receptor antagonist
Molecular Target Vasopressin 1a (V1a) receptor
Mechanism of ActionVasopressin 1 (V1) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today